Damage control.
D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology*; D015497:HIV-1; D006801:Humans; D008715:Methionine / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000502:physiology*
D018377:Neurotransmitter Agents; D008715:Methionine